The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009-2021.

ABSTRACT:

Background

Cardiometabolic disease is a clinical syndrome characterized by multiple metabolic disorders, with atherosclerosis as the core and cardiovascular and cerebrovascular events as the outcome. Drug research and development (R&D) in cardiometabolic diseases has grown rapidly worldwide. However, the development of cardiometabolic drug clinical trials in China remains unclear. This study aims to depict the changing landscape of drug clinical trials for cardiometabolic diseases in China during 2009-2021.

Methods

The detailed information of drug trials on cardiometabolic diseases registered in the National Medical Products Administration (NMPA) Registration and Information Disclosure Platform was collected between January 1, 2009, and July 1, 2021. The landscape of cardiom

SUBMITTER: Li C 

PROVIDER: S-EPMC10067219 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature